针对衰老瘤微环境的免疫治疗策略
Tadahito Yasuda1, Y Alan Wang2,3
1Brown Center for Immunotherapy, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. tayasuda@iu.edu.
British journal of cancer
|October 29, 2024
概括
细胞衰老会影响癌症免疫治疗的结果. 针对衰老细胞,特别是通过免疫调节策略,提供了一种有前途的方法,以克服固体瘤中治疗阻力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 细胞衰老在癌症中起着双重作用,可能促进免疫抑制瘤微环境 (TME) 或帮助免疫监测.
- 尽管癌症免疫疗法取得了进展,但在固体瘤,特别是晚期瘤中实现持久反应仍然是一个重大挑战.
- 在TME中,老化的地位越来越多地被认为对其对治疗耐药性的影响.
研究的目的:
- 审查针对癌症细胞衰老的最新进展.
- 专注于免疫调节方法来解决细胞衰老的特征.
- 突出克服与衰老细胞相关的治疗抵抗的策略.
主要方法:
- 关于细胞衰老和癌症免疫治疗的最新研究的文献综述.
- 对针对衰老细胞的免疫调节策略的分析.
- 综合了关于衰老在瘤微环境中的作用和治疗耐药性的信息.
主要成果:
- 细胞衰老在TME中呈现复杂的相互作用,影响免疫治疗的疗效.
- 针对衰老细胞,特别是通过免疫调节,是提高治疗结果的关键研究领域.
- 了解衰老的特征对于开发有效的治疗策略至关重要.
结论:
- 细胞衰老是影响癌症免疫治疗成功的关键因素.
- 免疫调节对衰老细胞的向具有显著的潜力,可以改善固体瘤的持久反应.
- 对老化剂和免疫调节组合的进一步研究是有必要的,以克服治疗耐药性.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


